ABVX

Abivax S.A.NASDAQHealthcare

$118.37+2.96%ClosedMarket Cap: $7.76B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-24	Barclays	—	Overweight	—
2026-02-25	BTIG	—	Buy	—
2026-01-09	Morgan Stanley	—	Overweight	—
2026-01-08	BTIG	—	Buy	—
2025-12-16	Citizens	—	Market Outperform	—
2025-10-10	Guggenheim	—	Buy	—
2025-10-07	BTIG	—	Buy	—
2025-09-25	JMP Securities	—	Market Outperform	—
2025-09-12	Morgan Stanley	—	Overweight	—
2025-07-29	Piper Sandler	—	Overweight	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-2.72	$131.7M	4
Sun Dec 31	$1.28	$660.8M	2
Mon Dec 31	$7.29	$1.34B	1
Tue Dec 31	$8.07	$1.74B	1